Melissa L. Johnson, MD, associate director for lung cancer research at Sarah Cannon Research Institute, stresses the importance of next-generation sequencing and plasma-based testing when planning patients’ treatment course.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2021 Healio All Rights Reserved.
Learn. Research. Collaborate.
Begin your journey with Learn Immuno-Oncology.
Test your knowledge and determine where to start.